Pretomanid is a dual inhibitor of the cytochrome bcc:aa3 and cytochrome bd oxidase that synergizes with Q203 to eradicate Mycobacterium tuberculosis
Tuberculosis is a global disease that carries with it high health and socio-economic burdens onto populations. Millions of people come down with the active form of the disease every year but the proportion of the world population that carries the latent form of this disease is believed to around...
Saved in:
Main Author: | Nurlilah Ab Rahman |
---|---|
Other Authors: | Kevin Pethe |
Format: | Thesis-Master by Research |
Language: | English |
Published: |
Nanyang Technological University
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/160530 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
The Mycobacterium tuberculosis cytochrome bcc:aa3 cryo-EM structure and discovery of novel putative cytochrome bcc:aa3 inhibitors
by: Mathiyazakan, Vikneswaran
Published: (2023) -
Antituberculosis activity of the antimalaria cytochrome bcc oxidase inhibitor SCR0911
by: Chong, Sherilyn Shi Min, et al.
Published: (2020) -
Cryo-electron microscopy structure of the Mycobacterium tuberculosis cytochrome bcc:aa₃ supercomplex and a novel inhibitor targeting subunit cytochrome cI
by: Mathiyazakan, Vikneswaran, et al.
Published: (2023) -
Targeting the menaquinol binding loop of mycobacterial cytochrome bd oxidase
by: Harikishore, Amaravadhi, et al.
Published: (2020) -
Features and functional importance of key residues of the Mycobacterium tuberculosis cytochrome bd oxidase
by: Sviriaeva, Ekaterina, et al.
Published: (2021)